Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 9.97 is 23% above its 5-year average of 8.10, around the middle of its 5-year range (0.04–25.94).
As of the fiscal period ended Tuesday, March 31, 2026. 4.60% above its 12-month average of 9.53.
Reported quarterly current ratio; no daily interpolation. Q4 FY2026 (2026-03-31): 9.97.
CURRENT RATIO
9.97
CURRENT RATIO AVG TTM
9.53
CURRENT RATIO AVG 3Y
12.04
CURRENT RATIO AVG 5Y
8.10
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+4.60%
CURRENT VS 3Y AVG
-17.23%
CURRENT VS 5Y AVG
+23.12%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+165.12%
vs the sector median at left
Virax Biolabs Group Limited
Market Cap
$378849.00
Current Ratio
9.97
TTM Avg
9.53
3Y Avg
12.04
5Y Avg
8.10
Market Cap
$403887.00
Current Ratio
0.78
TTM Avg
0.50
3Y Avg
0.69
5Y Avg
2.39
Market Cap
$481786.00
Current Ratio
3.59
TTM Avg
2.57
3Y Avg
4.32
5Y Avg
8.01
Market Cap
$110112.00
Current Ratio
0.94
TTM Avg
1.53
3Y Avg
2.70
5Y Avg
2.29
Market Cap
$95475.00
Current Ratio
8.09
TTM Avg
12.83
3Y Avg
6.46
5Y Avg
13.32
Market Cap
$667469.00
Current Ratio
7.93
TTM Avg
5.73
3Y Avg
3.60
5Y Avg
2.83
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Virax Biolabs Group Limited (VRAX) | $378849.00 | 9.97 | 9.53 | 12.04 | 8.10 |
| Niki BioSolutions, Inc. (NIKI)vs › | $403887.00 | 0.78 | 0.50 | 0.69 | 2.39 |
| XORTX Therapeutics Inc. (XRTX)vs › | $481786.00 | 3.59 | 2.57 | 4.32 | 8.01 |
| SciSparc Ltd. (SPRC)vs › | $250443.00 | 2.41 | 3.89 | 3.24 | 3.47 |
| VivoSim Labs, Inc. (VIVS)vs › | $518606.00 | 1.70 | 2.81 | 3.10 | 14.50 |
| HCW Biologics Inc. (HCWB)vs › | $545796.00 | 0.06 | 0.15 | 3.14 | 7.02 |
| Silexion Therapeutics Ltd. (SLXN)vs › | $110112.00 | 0.94 | 1.53 | 2.70 | 2.29 |
| Psyence Biomedical Ltd. (PBM)vs › | $95475.00 | 8.09 | 12.83 | 6.46 | 13.32 |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $667469.00 | 7.93 | 5.73 | 3.60 | 2.83 |
| PRF Technologies Ltd. (PRFX)vs › | $70884.00 | 5.07 | 1.79 | 4.80 | 10.47 |
Current Ratio
9.97
Quick Ratio
9.90
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-03-31 | 9.97 |
| 2025-09-30 | 11.35 |
| 2025-03-31 | 7.27 |
| 2024-09-30 | 11.58 |
| 2024-03-31 | 25.94 |
| 2023-09-30 | 7.59 |
| 2023-03-31 | 10.61 |
| 2022-09-30 | 4.64 |
| 2022-03-31 | 0.04 |
| 2021-09-30 | 0.04 |
| 2021-03-31 | 0.05 |
| 2020-09-30 | 0.00 |
| 2020-03-31 | 0.02 |
| 2019-09-30 | 0.00 |
